Genomic and mutational profiling of ductal carcinomas <i>in situ</i> and matched adjacent invasive breast cancers reveals intra‐tumour genetic heterogeneity and clonal selection
Lucía Hernández(Institute of Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Adriana Campion‐Flora(Institute of Cancer Research), Roger A’Hern, Britta Weigelt(Memorial Sloan Kettering Cancer Center), Rachael Natrajan(Institute of Cancer Research), Caterina Marchiò(Candiolo Cancer Institute), Alan Mackay(Institute of Cancer Research), Daniel Nava Rodrigues(Institute of Cancer Research), José Palacios(Universidad de Alcalá), Cecilia Cabral(Institute of Cancer Research), Maryou B. Lambros(Institute of Cancer Research), Arnaud Gauthier(Institute of Cancer Research), Paul M Wilkerson(University Hospitals Bristol NHS Foundation Trust), Vidya Pawar(Institute of Cancer Research)
Cited by 153
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
|New England Journal of Medicine|2012|1k